临床常见耐药菌株的现状及其治疗
摘要
抗生素的广泛应用,临床上出现了大量的耐药菌株,给疾病的治疗带来了很多的困难。所以,临床上常见的耐药菌株现状如何,又是如何治疗,需要我们进一步研究、探讨。
参考文献15
-
1韩启德.现代医学的回顾与展望[A];学术年会大会报告汇编[C].沈阳:中国科协,2003,9:10-20.
-
2陆权,陈慧中,杨永弘.制定与推广抗生素合理使用指南控制细菌耐药[J].中华儿科杂志,2002,40(8):458-460. 被引量：40
-
3Hartman BJ,Iomas A.Low affinity penicilling protein protein associated with β-lactam resistance in staphylococcus aureus[J].J Bact,1984,158:513-516.
-
4底建辉,沈叙庄,杨永弘.凝固酶阴性葡萄球菌感染的分子生物学研究进展[J].中华儿科杂志,2004,42(1):26-29. 被引量：9
-
5王增霞,吴明,蒋宁.替考拉宁提炼工艺的研究进展[J].国外医药（抗生素分册）,2004,25(2):87-91. 被引量：11
-
6董宗祈.β-内酰胺类抗生素的耐药机制及儿科临床对策[J].中国实用儿科杂志,2002,17(3):140-142. 被引量：22
-
7Christensen KJ,Gubbins PO.Treament vancomycin-resistant staphylococcal infections[J.Ann pharm,1996,30(3):228.
-
8肖永红.Linezolid:第一个应用于临床的噁唑啉酮类抗菌药[J].国外医药（抗生素分册）,2001,22(6):279-281. 被引量：11
-
9孟庆国,金洁,刘浚.噁唑烷酮类抗菌剂研究进展[J].中国新药杂志,2002,11(5):355-359. 被引量：11
-
10张胜权,吕利英,张书利,艾林.噁唑烷酮类抗菌药的研究进展[J].国外医药（抗生素分册）,2004,25(1):34-42. 被引量：9
二级参考文献89
-
1Liveremore DM. Linezolid in vitro: mechanism and antibacterial spectrum [J]. J Antimicrob Chemother. 2003,51(S2):119.
-
2Meagher AK, Forrest A, Rayner CA, et al. Population pharmacokinetics of linezolid in patients treated in a compassionate - use program [J ]. Antimicrob Agents Chemother,2003,47 (2) : 548.
-
3Eustice DC, Feldman PA, Slee AM. Mechanism of action of DuP- 721, a new antibacterial agent: effects on macromolecular sysntyhesis[J ]. Biochem Biophys Res Commun, 1988,150 : 965.
-
4Shinabarger DL, Marotti KR, Murray RW, et al. Mechanism of action of oxazolidinones: effects of Linezolid and eperezolid on translation reactions [J ]. Antirnicrob Agents Chemother,1997,41(10) : 2132.
-
5Swaney S M, Aoki H, Ganoza M C, et al. the oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria [J ].Antimicrob Agents Chernother , 1998,42(12) :3251.
-
6Kloss P, Xiong L, Shinabarger DL, et al. Resistance mutationd in 23S RNA identify the site of action of the protein synthesis inhibitor Linezolid in the ribosomal peptidyl transferase center [J]. J Mol Biol, 1999,294:93.
-
7Xiong L, Kloss P, Douthwaite S, et al. Oxazolidlnone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action[J]. J Bacteriol, 2000,182(19): 5325.
-
8Patal U, Yan YP, Hobbs FW Jr, et al. Oxazolidinones mechanism of action: inhibition of the first peptide bond formation [J]. J Biol Chem, 2001,276(40): 37199.
-
9Gregory WA, Brittelli DR, Wang CLJ, et al. Antibacterials. synthesis and Structure- activity studies of 3 - aryi - 2 -oxazolidinones. 1. the" B" group [J]. J Med Chem, 1989,32 : 1673.
-
10Tokuyama R, Takabashi Y, Tomita Y, et al. Structureactivity relationship (SAR) studies on oxazolidinone antibacterial agents. 1. conversion of 5 - substituent on oxazolidinone[J]. Chem Pharm Bull, 2001,49(4): 347.
共引文献148
-
1王月,高月麒,林旸,任风芝,张雪霞,李晓露.替考拉宁的分离纯化[J].中国抗生素杂志,2020(6):573-576.
-
2黄润英,肖吉群,黄均阳.败血症106例临床分析[J].中国医师杂志,2005,7(S1):289-291.
-
3李春霞,方怀天,毛菊秀,赵霞,潘万俊,李辉.儿童呼吸道卡他莫拉菌感染的防治[J].职业与健康,2004,20(7):137-138. 被引量：2
-
4汪咪珍.小儿抗生素相关性腹泻61例病原学分析[J].现代实用医学,2004,16(7):411-412. 被引量：3
-
5黄可文,陈肃.儿科感染致病菌96株耐药结果分析[J].宁夏医学杂志,2004,26(8):502-503.
-
6林玫,董柏青,梁大斌,廖和壮,谭冬梅,B.Nyambat,P.E.Kilgore.农村卫生室5岁以下儿童静脉用抗生素情况的调查分析[J].中国热带医学,2004,4(5):736-738. 被引量：1
-
7张孝祯,赵建军.小儿用药应注意的几个问题[J].实用神经疾病杂志,2004,7(6):68-69. 被引量：4
-
8周金梅,刘海滨.安奇治疗小儿急性细菌性呼吸道感染疗效观察[J].医师进修杂志,2004,27(11):50-51.
-
9徐浩,张洪振.临床G^+球菌与G^-杆菌常见的耐药菌株感染及其药物治疗的展望[J].沈阳医学院学报,2004,6(4):270-272.
-
10张佳玲,万朝敏,张伶俐,徐群芳.897例儿童上呼吸道感染抗生素治疗回顾分析[J].西部医学,2003,1(4):341-342. 被引量：6
